Theriva Historical Valuation

TOVX Stock  USD 1.34  0.06  4.69%   
Some fundamental drivers such as market cap or Theriva Biologics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Theriva Biologics valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Theriva Biologics's future value.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.

About Theriva Valuation Data Analysis

Valuation is the financial process of determining what Theriva Biologics is worth. Theriva Biologics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Theriva Biologics valuation ratios help investors to determine whether Theriva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theriva with respect to the benefits of owning Theriva Biologics security.

Theriva Biologics Valuation Data Chart

Market Cap is likely to drop to about 6 M in 2024. Enterprise Value is likely to rise to about (28.3 M) in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Theriva Biologics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Theriva Biologics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Theriva Biologics value than its market capitalization because it takes into account all of Theriva Biologics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.